In this article4 sections
Injective signed a memorandum of understanding with South Korean digital asset custodian BDACS on October 20, 2026 to bring KRW1, a Korean won-backed stablecoin, into its real-world asset ecosystem, Ambcrypto reports. The two firms aim to develop won-denominated settlement for tokenized assets and RWA tokenization. Under the plan, KRW1 — issued by BDACS — would serve as a settlement currency for institutions trading tokenized assets on the Injective network.
The arrangement stops short of a live product in every respect: minting and redemption would begin with approved institutional partners and require regulatory approval. Ambcrypto framed whether the token pulls capital back onshore as a question of adoption and of which markets become available.
Also read: China P2P stablecoin wallets grew 43-fold, Chainalysis finds
Key facts
- KRW1 is fully backed by Korean won, with 100% of the collateral held in escrow at Woori Bank and verified in real time through banking APIs, according to Cryptobriefing. Ambcrypto described the reserves as held at “a major Korean bank.”
- KRW1’s on-chain supply stood at approximately 13.67 million as of October 20, 2026 (Cryptobriefing); Ambcrypto said the company mentioned reserves held at a major Korean bank without giving that supply figure.
- South Korea’s five largest exchanges recorded 18 consecutive months of net stablecoin outflows. Coincentral put the total at about $10.4 billion, while Ambcrypto cited roughly $10 billion.
- BDACS CEO Harry Ryoo said demand in tokenized markets will stay tied to dollar stablecoins without on-chain won infrastructure, according to Coincentral.
- South Korea aims to finalize its Digital Asset Basic Act by the end of 2026; Coincentral reported the bill is in final government consultation and slated for discussion at the national legislature next month.
What each report adds
Cryptobriefing gave the most detail on the token’s backing and history: the escrow arrangement at Woori Bank, live bank-API verification of reserves, and a proof-of-concept that concluded on September 18, 2025 on the Avalanche network with Woori Bank. It said the token has since spread to Ethereum and BNB Chain, with cross-chain movement using LayerZero’s OFT standard. It also reported that KRW1 is still awaiting further regulatory approval.
Coincentral described KRW1 as the exclusive won-denominated settlement asset for real-world assets on Injective and reported BDACS held more than 80 billion won in assets under custody in the first half of 2026. It also noted Injective has processed more than $7.5 billion in real-world asset volume, with over $1 billion in tokenized assets issued on the network, and that Injective’s institutional arm registered with the US Securities and Exchange Commission as a transfer agent in August.
Also read: Injective climbs 10% as Gulf Labs becomes institutional validator
Ambcrypto put the stablecoin market in context, citing Allium data showing total stablecoin supply of $336 billion and adjusted supply of $311 billion. It also reported Injective’s prior work with POSCO International and LG CNS, and said Pineapple Financial had announced plans days earlier to tokenize a $10 billion mortgage portfolio.
Why it matters
Dollar-backed tokens dominate stablecoin activity, and in Korea that has meant capital and settlement volume routing offshore before tokenized assets can trade. A won-denominated option would let Korean institutions settle on-chain without first moving through a dollar stablecoin, which is where BDACS’s role as a custodian and its reserve transparency come in. For Injective, the deal adds a non-dollar settlement currency to an RWA strategy that already counts Korean corporate users. For BDACS, Injective is another distribution channel.
On Injective itself, on-chain capital has been climbing: Ambcrypto reported total value locked rebounded by more than $2 million in under two weeks, while stablecoin market cap rose from $12 million to $17 million. Those figures show capital arriving, though sustained transaction activity would be the stronger signal of real use.
What to watch
The clearest near-term markers are Korea’s Digital Asset Basic Act, which the government aims to finalize by the end of 2026, and whether KRW1’s on-chain supply rises meaningfully after landing on Injective. Approval for institutional minting and redemption, and any pricing or settlement announcements from trading venues and RWA issuers, would indicate whether won-based settlement is actually being used.
Ambcrypto said INJ could target $10 in the short term if adoption strengthens and buyers maintain momentum, but described that as a conditional outlook and said the partnership alone does not establish a price target. This is not financial advice; crypto markets are volatile and uncertain.
Reported by ambcrypto.com.
Sources: AMBCrypto, Cryptobriefing, Coincentral